Business Context and Reporting Period
This Form 8-K Current Report was filed by DaVita HealthCare Partners Inc. on April 14, 2015. The filing primarily addresses corporate actions taken by the Board of Directors on this date and the incorporation of updated risk factors into the company's Registration Statement on Form S-3.
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The only financial figures disclosed relate to capital allocation:
- New Share Repurchase Authorization: Approximately $725,944,000.
- Remaining Authorization under Existing Program: Approximately $274,056,000.
- Total Available for Repurchase: Approximately $1,000,000,000 (combined).
Material Changes
The material change reported is the Board's approval of a new share repurchase program. This new authorization is in addition to the remaining balance of the program announced on November 4, 2010. Neither program has an expiration date, and the company is not obligated to purchase any shares.
Guidance, Outlook, and Risks
The filing incorporates updated "Risk Factors" (Exhibit 99.1) into the company's Form S-3 registration statement. The document contains forward-looking statements regarding anticipated refinancing, future operations, financial condition, treatment growth rates, revenue per treatment, expense growth, and the impact of indebtedness on earnings per share. Management notes that actual results may differ materially from these statements due to known and unknown risks.
Investor Verification Checklist
- Verify the total remaining authorization for share repurchases ($1 billion combined).
- Review the updated "Risk Factors" attached as Exhibit 99.1 for new disclosures regarding the company's business.
- Confirm that the repurchase programs have no expiration date and can be suspended or discontinued at any time.
- Note that this filing does not contain updated quarterly or annual financial performance data.